Published in Nat Clin Pract Endocrinol Metab on November 01, 2006
Glucose sensing in L cells: a primary cell study. Cell Metab (2008) 5.53
Central control of body weight and appetite. J Clin Endocrinol Metab (2008) 1.91
Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia (2007) 1.21
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Recent advances in gut nutrient chemosensing. Curr Med Chem (2012) 0.96
Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels. Int J Obes (Lond) (2010) 0.96
The paradox of the pouch: prompt emptying predicts improved weight loss after laparoscopic Roux-Y gastric bypass. Surg Endosc (2008) 0.94
Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction. Mol Cell Endocrinol (2008) 0.89
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nat Rev Gastroenterol Hepatol (2012) 0.87
Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes (2008) 0.86
Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor. Am J Physiol Gastrointest Liver Physiol (2009) 0.81
Transplantation of PC1/3-Expressing alpha-cells improves glucose handling and cold tolerance in leptin-resistant mice. Mol Ther (2008) 0.81
Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol Metab (2015) 0.79
Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. Exp Neurol (2016) 0.75
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options. Pharmaceuticals (Basel) (2010) 0.75
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology (2004) 1.31
Gastrointestinal satiety signals. Annu Rev Physiol (2008) 1.27
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab (2006) 1.26
The role of gut hormones and the hypothalamus in appetite regulation. Endocr J (2010) 1.24
Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol (2010) 1.23
The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci (2003) 1.22
Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology (2012) 1.20
Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg (2010) 1.20
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr (2007) 1.19
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol (2005) 1.18
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver (2012) 1.16
Gut hormones and the control of appetite. Trends Endocrinol Metab (2004) 1.15
Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab (2005) 1.14
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res (2005) 1.14
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes (2012) 1.13
Ghrelin for the gastroenterologist: history and potential. Gastroenterology (2003) 1.12
Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology (2004) 1.12
Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab (2009) 1.11
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab (2011) 1.08
Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab (2005) 1.08
Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun (2006) 1.07
Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) (2009) 1.06
Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care (2006) 1.05
Obesity and appetite control. Exp Diabetes Res (2012) 1.05
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology (2003) 1.04
Sexual dimorphism of kisspeptin and neurokinin B immunoreactive neurons in the infundibular nucleus of aged men and women. Front Endocrinol (Lausanne) (2011) 1.02
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab (2005) 1.02
A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr (2003) 1.01
Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol (2009) 1.01
Peptides and their potential role in the treatment of diabetes and obesity. Rev Diabet Stud (2011) 1.01
Can gut hormones control appetite and prevent obesity? Diabetes Care (2008) 1.00
Minireview: Gut peptides regulating satiety. Endocrinology (2004) 0.99
Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg (2007) 0.98
Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes (2009) 0.98
Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. Eur J Endocrinol (2008) 0.96
Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake. Diabetes (2009) 0.96
Obesity treatment: novel peripheral targets. Br J Clin Pharmacol (2009) 0.95
Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab (2006) 0.94
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J Clin Endocrinol Metab (2004) 0.94
Ghrelin and appetite control in humans--potential application in the treatment of obesity. Peptides (2011) 0.94
The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology (2002) 0.94
Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron concept. Endocrinology (2012) 0.93
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes (2010) 0.92
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr (2011) 0.91
The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology (2002) 0.91
The neuroendocrine physiology of kisspeptin in the human. Rev Endocr Metab Disord (2007) 0.91
Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab (2002) 0.90
The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology (2010) 0.90
Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides (2006) 0.89
The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients. Clin Nutr (2006) 0.89
Gut-brain cross-talk in appetite regulation. Curr Opin Clin Nutr Metab Care (2010) 0.89
Oxyntomodulin : a novel potential treatment for obesity. Treat Endocrinol (2006) 0.89
A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab (2009) 0.89
Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript. Clin Chem (2012) 0.89
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr (2007) 0.89
PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones. Am J Physiol Endocrinol Metab (2008) 0.88
Overexpression of CART in the PVN increases food intake and weight gain in rats. Obesity (Silver Spring) (2008) 0.88
Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake. Ann Clin Biochem (2008) 0.88
The gut hormones in appetite regulation. J Obes (2011) 0.88
Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr (2007) 0.88
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am J Physiol Endocrinol Metab (2002) 0.87
Novel therapeutic targets for appetite regulation. Curr Opin Investig Drugs (2005) 0.87
Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol (2002) 0.87
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr (2002) 0.87
Gut hormones as peripheral anti obesity targets. Curr Drug Targets CNS Neurol Disord (2004) 0.87
The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol (Oxf) (2004) 0.86